4//SEC Filing
Nayak Asha 4
Accession 0001562180-17-003515
CIK 0001597553other
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 5:02 PM ET
Size
5.5 KB
Accession
0001562180-17-003515
Insider Transaction Report
Form 4
Nayak Asha
Director
Transactions
- Award
Stock Options (Right to buy)
2017-11-06+20,883→ 20,883 totalExercise: $65.49Exp: 2027-11-06→ Common Stock (20,883 underlying)
Footnotes (1)
- [F1]All of the shares subject to the option vest monthly measured from November 6, 2017 (the "Grant Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the Third anniversary of the Grant Date, subject to continued service through such date.
Documents
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeother
Related Parties
1- filerCIK 0001722119
Filing Metadata
- Form type
- 4
- Filed
- Nov 7, 7:00 PM ET
- Accepted
- Nov 8, 5:02 PM ET
- Size
- 5.5 KB